Stepwise increase of fidaxomicin in an engineered heterologous host Streptomyces albus through multi-level metabolic engineering

The anti-Clostridium difficile infection (CDI) drug fidaxomicin is a natural polyketide metabolite mainly produced by Micromonosporaceae, such as Actinoplanes deccanensis, Dactylosporangium aurantiacum, and Micromonospora echinospora. In the present study, we employed a stepwise strategy by combinin...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Synthetic and Systems Biotechnology
المؤلفون الرئيسيون:	Huang Xie, Yi-Ting Su, Qing-Ting Bu, Yue-Ping Li, Qing-Wei Zhao, Yi-Ling Du, Yong-Quan Li
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	KeAi Communications Co., Ltd. 2024-12-01
الموضوعات:	Fidaxomicin Heterologous expression Streptomyces albus Genome-reduced chassis Metabolic engineering
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S2405805X24000930

مواد مشابهة

Rational engineering of Streptomyces albus J1074 for the overexpression of secondary metabolite gene clusters
حسب: Dimitris Kallifidas, وآخرون
منشور في: (2018-02-01)

Engineering the TetR-family transcriptional regulator XNR_0706 to enhance heterologous spinosad production in Streptomyces albus B4 chassis
حسب: Xingjun Cui, وآخرون
منشور في: (2025-03-01)

Identification and Heterologous Expression of the Albucidin Gene Cluster from the Marine Strain <i>Streptomyces Albus</i> Subsp. <i>Chlorinus</i> NRRL B-24108
حسب: Maksym Myronovskyi, وآخرون
منشور في: (2020-02-01)

Reconstruction of a Genome-Scale Metabolic Model of <i>Streptomyces albus</i> J1074: Improved Engineering Strategies in Natural Product Synthesis
حسب: Cheewin Kittikunapong, وآخرون
منشور في: (2021-05-01)

Dudomycins: New Secondary Metabolites Produced after Heterologous Expression of an Nrps Cluster from <i>Streptomyces albus</i> ssp. <i>Chlorinus</i> Nrrl B-24108
حسب: Constanze Lasch, وآخرون
منشور في: (2020-11-01)

Increasing the heterologous production of spinosad in Streptomyces albus J1074 by regulating biosynthesis of its polyketide skeleton
حسب: Ziheng An, وآخرون
منشور في: (2021-12-01)

Heterologous Expression of Type II PKS Gene Cluster Leads to Diversified Angucyclines in <i>Streptomyces albus</i> J1074
حسب: Xiaoting Zhang, وآخرون
منشور في: (2024-10-01)

A highly efficient heterologous expression platform to facilitate the production of microbial natural products in Streptomyces
حسب: Xiuling Wang, وآخرون
منشور في: (2025-05-01)

Clostridium difficile colitis in an immunocompromised patient treated with fidaxomicin
حسب: Marcello Feasi
منشور في: (2015-05-01)

Transcriptional regulation of the fidaxomicin gene cluster and cellular development in Actinoplanes deccanensis YP-1 by the pleiotropic regulator MtrA
حسب: Huang Xie, وآخرون
منشور في: (2023-12-01)

Salumycin, a New Pyrazolequinone from a <i>Streptomyces albus</i> J1074 Mutant Strain
حسب: Kaixiang Tao, وآخرون
منشور في: (2020-09-01)

Eosinophilic tracheobronchitis with cough hypersensitivity caused by Streptomyces albus antigen
حسب: Haruhiko Ogawa, وآخرون
منشور في: (2000-01-01)

In vitro activity of fidaxomicin and combinations of fidaxomicin with other antibiotics against Clostridium perfringens strains isolated from dogs and cats
حسب: Sergio Álvarez-Pérez, وآخرون
منشور في: (2023-11-01)

Rational construction of genome-reduced and high-efficient industrial Streptomyces chassis based on multiple comparative genomic approaches
حسب: Qing-Ting Bu, وآخرون
منشور في: (2019-01-01)

Comprehensive dissection of dispensable genomic regions in Streptomyces based on comparative analysis approach
حسب: Qing-Ting Bu, وآخرون
منشور في: (2020-05-01)

Recent Advances in the Heterologous Biosynthesis of Natural Products from <i>Streptomyces</i>
حسب: Van Thuy Thi Pham, وآخرون
منشور في: (2021-02-01)

Fidaxomicin in the treatment of colitis due to Clostridium difficile: preliminary results
حسب: Francesco Cortese, وآخرون
منشور في: (2014-12-01)

Fidaxomicin: A new fight against clostridium difficile-associated diarrhea
حسب: Dick B. S. Brashier, وآخرون
منشور في: (2014-01-01)

Chassis optimization as a cornerstone for the application of synthetic biology based strategies in microbial secondary metabolism
حسب: Tiago eBeites, وآخرون
منشور في: (2015-09-01)

Engineering of Burkholderia thailandensis strain E264 serves as a chassis for expression of complex specialized metabolites
حسب: Zong-Jie Wang, وآخرون
منشور في: (2022-11-01)

Rational construction of genome-minimized Streptomyces host for the expression of secondary metabolite gene clusters
حسب: Hui Li, وآخرون
منشور في: (2024-09-01)

High in vitro activity of fidaxomicin against Clostridium difficile isolates from a university teaching hospital in China
حسب: Jing-Wei Cheng, وآخرون
منشور في: (2018-06-01)

Heterologous expression of pikromycin biosynthetic gene cluster using Streptomyces artificial chromosome system
حسب: Hye-rim Pyeon, وآخرون
منشور في: (2017-05-01)

Decreased warfarin effects in elder with recurrent Clostridium difficile infection during fidaxomicin therapy: a case report
حسب: Antonio Riccardo Buonuomo, وآخرون
منشور في: (2015-03-01)

In vitro susceptibility of clinical Clostridioides difficile isolates in Israel to metronidazole, vancomycin, fidaxomicin, ridinilazole and ibezapolstat,
حسب: Orna Schwartz, وآخرون
منشور في: (2025-03-01)

A VioA Variant Activates Antibiotic Streptogramins in the Heterologous Host <i>Streptomyces</i> sp. OUC20-O
حسب: Jie Shan, وآخرون
منشور في: (2025-05-01)

Comparison of fidaxomicin, thuricin CD, vancomycin and nisin highlights the narrow spectrum nature of thuricin CD
حسب: L. Walsh, وآخرون
منشور في: (2024-12-01)

Development of an antibiotic marker-free platform for heterologous protein production in Streptomyces
حسب: Laura Sevillano, وآخرون
منشور في: (2017-09-01)

The Risk of <i>Clostridioides difficile</i> Recurrence after Initial Treatment with Vancomycin or Fidaxomicin Utilizing Cerner Health Facts
حسب: Ronald G. Hall, وآخرون
منشور في: (2022-02-01)

Heterologous expression of Avermectins biosynthetic gene cluster by construction of a Bacterial Artificial Chromosome library of the producers
حسب: Qian Deng, وآخرون
منشور في: (2017-03-01)

Extracellular production of the engineered thermostable protease pernisine from Aeropyrum pernix K1 in Streptomyces rimosus
حسب: Marko Šnajder, وآخرون
منشور في: (2019-11-01)

Two-Component-System RspA1/A2-Dependent Regulation on Primary Metabolism in Streptomyces albus A30 Cultivated With Glutamate as the Sole Nitrogen Source
حسب: Kuipu Zhang, وآخرون
منشور في: (2020-07-01)

Does Fidaxomicin reduce Cure and Recurrence rates compared to Vancomycin in Clostridium Difficile Infection patients?: A Systematic Review and Meta-analysis
حسب: Hiral N Golakiya, وآخرون
منشور في: (2022-06-01)

A Promiscuous Halogenase for the Derivatization of Flavonoids
حسب: Dominik Kolling, وآخرون
منشور في: (2021-10-01)

The TetR-like regulator Sco4385 and Crp-like regulator Sco3571 modulate heterologous production of antibiotics in Streptomyces coelicolor M512
حسب: Sarah Wilcken, وآخرون
منشور في: (2025-05-01)

Heterologous Biosynthesis of Health-Promoting Baicalein in <i>Lycopersicon esculentum</i>
حسب: Jingjing Liao, وآخرون
منشور في: (2022-05-01)

Multiplexed Promoter Engineering for Improving Thaxtomin A Production in Heterologous <i>Streptomyces</i> Hosts
حسب: Xuejin Zhao, وآخرون
منشور في: (2022-05-01)

Miramides A–D: Identification of Detoxin-like Depsipeptides after Heterologous Expression of a Hybrid NRPS-PKS Gene Cluster from <i>Streptomyces mirabilis</i> Lu17588
حسب: Constanze Paulus, وآخرون
منشور في: (2022-08-01)

Discovery and Heterologous Production of New Cyclic Depsibosamycins
حسب: Marc Stierhof, وآخرون
منشور في: (2021-06-01)

Comparison of fidaxomicin, metronidazole and vancomycin for initial episode and recurrence of Clostridioides difficile infection - An observational cohort study
حسب: Marcos Hernando-Gozalo, وآخرون
منشور في: (2024-05-01)